Ottensmeier, Professor Christian

MD PhD FRCP

Speciality

Medical Oncology

Sub-speciality

Thoracic Malignancies, Skin Cancer, Immunotherapy,

Training and Education

1986 Medical Degree;
1989 MD (Münster, Germany); 1999 PhD (Southampton);
1997 CCST in Medical Oncology               

Experience

Professor Ottensmeier has worked for Southampton University Hospitals Trust since February 1994. 

1991-1993 Research Fellow, Dana Farber Cancer Institute Boston, US;

1999 Senior Lecturer and Consultant in Medical Oncology;                 

2007 Professor of Experiimental Cancer Medicine

Key achievements

Chair in Experimental Cancer Medicine;
CRUK Senior Clinical Research Fellow since 1999;
Programme Grant Holder Cancer Research UK; 
Programme Grant Holder Leukemia Resarch Fund;
Programme Grant Holder and lead Experimental Cancer Medicine Centre Southampton     

Research

McCann, K.J., Ashton-Key, M., Smith, K.A., Stevenson, F.K., and Ottensmeier, C.H.H. (2008). Primary CNS lymphoma: tumor-related clones exist in the blood and bone marrow with evidence for separate development. Blood, in press.

Ottensmeier, C.H.H., et al  (2008). DNA fusion gene vaccination, delivered with or without in vivo electroporation - a potent and safe strategy for inducing anti-tumor immune responses in prostate cancer. In American Society of Gene Therapy, 11th Annual Meeting. (Boston, MA, USA), p. Abstract 450987.

Rice, J., Ottensmeier, C.H., and Stevenson, F.K. (2008). DNA vaccines: precision tools for activating effective immunity against cancer. Nat Rev Cancer 8, 108-120

McCann, K.J., Johnson, P.W., Stevenson, F.K., and Ottensmeier, C.H. (2006). Universal N-glycosylation sites introduced into the B-cell receptor of follicular lymphoma by somatic mutation: a second tumorigenic event? Leukemia 20, 530-534.